rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Weis Markets, Inc.

WMK · NYSE

Consumer StaplesMass, Grocery & Drug RetailJust started moving

WMK stood above a rising 150-day average in 16 of the last 52 weekly readings, including each of the last 3 weeks. It is 1.3% above that average now. Mass, Grocery & Drug Retail: 35% of its 26 stocks in an uptrend (±0 points in four weeks); Consumer Staples: 23% (+1 points in four weeks).

Statistics

Rotation
Just started moving
Weeks in an uptrend
3 in a row
Industry in uptrend
35% 0 in 4 wk
Insider buys, 12 months
$33K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
186 (+20)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 16 of 52 weeks.

20 Apr – 19 Oct
20%36%53%Apr 26Jun 26Jul 26Sep 26Oct 26

Mass, Grocery & Drug Retail: A minority of its stocks are in an uptrend and the share has held steady. Consumer Staples: A minority of its stocks are in an uptrend and the share has held steady.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$255.4M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1
Sale orders, 12 months0
Buyers · sellers1 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders186+20 on the quarter
New · exited35 · 16
Reported value$904.0M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 20261,998,715$156.5M-6,890−0.3%
BlackRock, Inc.added · filed 7 Aug 20261,218,454$95.4M+101,149+9.1%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026846,751$66.3M+1,739+0.2%
AMERICAN CENTURY COMPANIES INCadded · filed 12 Aug 2026748,696$58.6M+111,211+17.4%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026564,623$44.2M+8,411+1.5%
STATE STREET CORPadded · filed 7 Aug 2026408,303$32.0M+14,786+3.8%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026286,650$22.5M+2,103+0.7%
TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 2026276,844$21.7M+48,326+21.1%
Bank of New York Mellon Corpreduced · filed 6 Aug 2026269,835$21.1M-2,377−0.9%
Allianz Asset Management GmbHadded · filed 14 Aug 2026251,347$19.7M+14,214+6.0%
31 Mar 2023 – 30 Jun 2026
119152184Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Jonathan H. Weis Company insiderCEO, Chairman of the Board · last 1 Jun 20261 · 0
Patricia R. Weis Marital Trust Company insider10% owner · last 1 Jun 20260 · 1
Robert G. Gleeson Company insiderChief Operating Officer · last 7 Nov 20254 · 0
Patricia G. Ross Weis Company insider10% owner · last 6 Jun 20250 · 1
Edward John Lauth III Company insiderDirector · last 10 May 20242 · 0
Kurt A. Schertle Company insiderChief Operating Officer · last 31 May 20234 · 0
Michael T. Lockard Company insiderSVP, CFO and Treasurer · last 9 Dec 20211 · 0
Jennifer Weis Company insiderOther · last 29 Oct 20210 · 0
Scott F. Frost Company insiderSVP, Chief Financial Officer · last 3 Jun 20195 · 0
Wayne S. Bailey Company insiderSVP Supply Chain · last 21 May 20192 · 0
Dennis G. Hatchell Company insiderDirector · last 7 Nov 20172 · 0
Gerrald B. Silverman Company insiderDirector · last 7 Nov 20171 · 0

Same industry

TBBB BBB FoodsLeading+37%
TGT TargetLeading+11%
FIVE Five BelowJust started moving+3%
GRDN Guardian Pharmacy ServicesJust started moving+2%
CVS CVS HealthJust started moving+1%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 27 Dec 202525.0%
Operating profit marginFY 2025 · to 27 Dec 20252.3%
Free cash flow marginFY 2025 · to 27 Dec 20250.1%
Return on capital employedFY 2025 · to 27 Dec 20256.8%
Cash conversionFY 2025 · to 27 Dec 2025221%
Earnings per share growthFY 2025 · to 27 Dec 2025429%
Share count trendFY 2025 · to 12 Mar 20260.0%
Cash and equivalentsFY 2025 · to 27 Dec 2025$117.1M
Free cash flowFY 2025 · to 27 Dec 2025$4.8M

Analyst forecasts

No analyst forecasts yet.